529 related articles for article (PubMed ID: 17576868)
1. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
[TBL] [Abstract][Full Text] [Related]
5. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
Groenning BA; Nilsson JC; Hildebrandt PR; Kjaer A; Fritz-Hansen T; Larsson HB; Sondergaard L
Eur J Heart Fail; 2002 Oct; 4(5):635-46. PubMed ID: 12413508
[TBL] [Abstract][Full Text] [Related]
6. Metoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure.
Hole T; Frøland G; Gullestad L; Offstad J; Skjaerpe T
Echocardiography; 2004 Apr; 21(3):215-23. PubMed ID: 15053783
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
[TBL] [Abstract][Full Text] [Related]
8. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
Groenning BA; Nilsson JC; Sondergaard L; Fritz-Hansen T; Larsson HB; Hildebrandt PR
J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of beta-adrenergic blockade on left ventricular function in haemodialysis patients.
Hara Y; Hamada M; Shigematsu Y; Murakami B; Hiwada K
Clin Sci (Lond); 2001 Sep; 101(3):219-25. PubMed ID: 11524038
[TBL] [Abstract][Full Text] [Related]
10. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
[TBL] [Abstract][Full Text] [Related]
11. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
[TBL] [Abstract][Full Text] [Related]
12. Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch.
Benedetto U; Melina G; Refice S; di Bartolomeo R; Roscitano A; Angeloni E; Sinatra R
Ann Thorac Surg; 2010 Dec; 90(6):1899-903; discussion 1903. PubMed ID: 21095333
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
[TBL] [Abstract][Full Text] [Related]
14. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study.
Linde C; Gold M; Abraham WT; Daubert JC;
Congest Heart Fail; 2008; 14(2):66-74. PubMed ID: 18401214
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
[TBL] [Abstract][Full Text] [Related]
17. MY APPROACH to the patient with heart failure and improved ejection fraction
Cohn JN
Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
[No Abstract] [Full Text] [Related]
18. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
[TBL] [Abstract][Full Text] [Related]
19. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
Zacà V; Rastogi S; Mishra S; Wang M; Sharov VG; Gupta RC; Goldstein S; Sabbah HN
Cardiology; 2009; 112(4):294-302. PubMed ID: 18832825
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
